Assessment of Treatment Response Between Donor SpecificAntibodies and Forced Expiratory Volume in Lung Transplant Recipients with Donor Specific Antibodies

被引：0
|
作者：
Brenner, A. S. [1 ]
Klein, K. [1 ]
Hall, R. [1 ]
Keyt, H. [2 ]
Hitchman, K. [2 ]
Kincaide, E. [1 ]
机构：
[1] Univ Hlth Syst, Pharm, San Antonio, TX USA
[2] Univ Texas Hlth San Antonio, San Antonio, TX USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C259
引用
收藏
页码：S1029 / S1030
页数：2
相关论文
共 50 条
  • [31] Donor predicted post-operative forced expiratory volume in one second predicts recipients' best forced expiratory volume in one second following size-reduced lung transplantation
    Inci, Ilhan
    Irani, Sarosh
    Kestenholz, Peter
    Benden, Christian
    Boehler, Annette
    Weder, Walter
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2011, 39 (01) : 115 - 119
  • [32] PERSISTENT DE NOVO DONOR-SPECIFIC ANTIBODIES ARE ASSOCIATED WITH DECREASED SURVIVAL IN LUNG TRANSPLANT RECIPIENTS
    Kauke, Teresa
    Schmitzer, Magdalena
    Kneidinger, Nikolaus
    Neurohr, Claus
    Schramm, Rene
    Von Dossow, Vera
    Winter, Hauke
    TRANSPLANT INTERNATIONAL, 2017, 30 : 33 - 33
  • [33] Increased risk for bronchiolitis obliterans in lung transplant recipients who develop post transplant donor specific HLA antibodies
    Zeevi, A.
    Spichty, K.
    Joseph, P.
    Diana, Z.
    Crespo, M.
    Toyoda, Y.
    Morrell, M.
    TISSUE ANTIGENS, 2011, 77 (05): : 386 - 386
  • [34] INCREASED RISK FOR BRONCHIOLITIS OBLITERANS IN LUNG TRANSPLANT RECIPIENTS WHO DEVELOP POST TRANSPLANT DONOR SPECIFIC HLA ANTIBODIES
    Spichty, Kathy
    Morrell, Matthew
    Pilewski, Joseph
    Zaldonis, Diana
    Crespo, Maria
    Toyoda, Yoshiya
    Zeevi, Adriana
    HUMAN IMMUNOLOGY, 2011, 72 : S79 - S79
  • [35] PRE-TRANSPLANT DONOR SPECIFIC HLA ANTIBODIES DO NOT PREDICT BRONCHIOLITIS OBLITERANS SYNDROME IN LUNG TRANSPLANT RECIPIENTS
    Fidler, Samantha J.
    Dunne, Ben
    Gabbay, Eli
    Lavender, Melanie
    D'Orsogna, Lloyd
    Musk, Michael
    TISSUE ANTIGENS, 2013, 81 (05): : 324 - 324
  • [36] Five-Year Experience with Treatment of Early Donor Specific Anti-HLA Antibodies in Pediatric Lung Transplant Recipients
    Ius, F.
    Schwerk, N.
    Mueller, C.
    Sommer, W.
    Verboom, M.
    Hallensleben, M.
    Salman, J.
    Siemeni, T.
    Kuehn, C.
    Avsar, M.
    Bobylev, D.
    Carlens, J.
    Bayir, L.
    Hansen, G.
    Blasczyk, R.
    Haverich, A.
    Tudorache, I.
    Warnecke, G.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S61 - S61
  • [37] DILUTION STUDIES ESTABLISH HLA DONOR-SPECIFIC ANTIBODIES AS A PREDICTIVE BIOMARKER FOR SELECTION OF AMR TREATMENT IN LUNG TRANSPLANT RECIPIENTS
    Timofeeva, Olga A.
    Carney, Kevin
    Choe, Jason
    Yoon, Edward
    Alsammak, Mohamed
    Geier, Steven S.
    Brown, James
    Au, Jenny
    Cordova, Francis
    Shigemura, Norihisa
    Toyoda, Yoshiya
    Shenoy, Kartik
    Mamary, Albert
    HUMAN IMMUNOLOGY, 2019, 80 : 161 - 161
  • [38] The Correlation Between Donor Specific Antibodies and Heart Transplant Rejection
    Bedard, R.
    Jindra, P.
    Manson, M.
    Moaddab, M.
    Mallidi, H.
    Etheridge, W.
    Civitello, A.
    Kerman, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [39] Stratification of Immunologic Risk in Renal Transplant Recipients With Donor Specific Antibodies.
    Savchik, C.
    Calp, S.
    Turgut, D.
    Patel, N.
    Colovai, A.
    Akalin, E.
    TRANSPLANTATION, 2014, 98 : 876 - 876
  • [40] Outcomes in Kidney Transplant Recipients That Develop De Novo Donor Specific Antibodies
    DeVos, J. M.
    Patel, S. J.
    Land, G.
    Knight, R. J.
    Achkar, K.
    Dilioglou, S.
    Dawson, K. L.
    Abdellatif, A.
    Gaber, A. O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 294 - 294
12345